Evidence map›Paper›PMID 26615195›Full record

ArticleNucleic acids research2016

Where does transcription start? 5'-RACE adapted to next-generation sequencing.

Fleur A D Leenen, Sara Vernocchi, Oliver E Hunewald, Stephanie Schmitz, Anne M Molitor, Claude P Muller, Jonathan D Turner

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. BSGatlas: a unifiedMicrobial genomics · 2021
    Article
  7. The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Fleur A D LeenenDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-Sur-Alzette L-4354, Grand-Duchy of Luxembourg Department of Immunology, Research Institute of Psychobiology, University of Trier, Trier D-54290, Germany.
Sara VernocchiDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-Sur-Alzette L-4354, Grand-Duchy of Luxembourg Department of Immunology, Research Institute of Psychobiology, University of Trier, Trier D-54290, Germany.
Oliver E HunewaldDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-Sur-Alzette L-4354, Grand-Duchy of Luxembourg.
Stephanie SchmitzDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-Sur-Alzette L-4354, Grand-Duchy of Luxembourg.
Anne M MolitorDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-Sur-Alzette L-4354, Grand-Duchy of Luxembourg.
Claude P MullerDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-Sur-Alzette L-4354, Grand-Duchy of Luxembourg Department of Immunology, Research Institute of Psychobiology, University of Trier, Trier D-54290, Germany Claude.Muller@lih.lu.
Jonathan D TurnerDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-Sur-Alzette L-4354, Grand-Duchy of Luxembourg.
Luxembourg Institute of Health · LUUniversität Trier · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The variability and complexity of the transcription initiation process was examined by adapting RNA ligase-mediated rapid amplification of 5' cDNA ends (5'-RACE) to Next-Generation Sequencing (NGS). We oligo-labelled 5'-m(7)G-capped mRNA from two genes, the simple mono-exonic Beta-2-Adrenoceptor (ADRB2R)and the complex multi-exonic Glucocorticoid Receptor (GR, NR3C1), and detected a variability in TSS location that has received little attention up to now. Transcription was not initiated at a fixed TSS, but from loci of 4 to 10 adjacent nucleotides. Individual TSSs had frequencies from <0.001% to 38.5% of the total gene-specific 5' m(7)G-capped transcripts. ADRB2R used a single locus consisting of 4 adjacent TSSs. Unstimulated, the GR used a total of 358 TSSs distributed throughout 38 loci, that were principally in the 5' UTRs and were spliced using established donor and acceptor sites. Complete demethylation of the epigenetically sensitive GR promoter with 5-azacytidine induced one new locus and 127 TSSs, 12 of which were unique. We induced GR transcription with dexamethasone and Interferon-γ, adding one new locus and 185 additional TSSs distributed throughout the promoter region. In-vitro the TSS microvariability regulated mRNA translation efficiency and the relative abundance of the different GRN-terminal protein isoform levels.

Indexed as

Nucleic Acid Amplification TechniquesTranscription Initiation, GeneticTranscription Initiation Site5' Untranslated RegionsAzacitidineCell Line, TumorDexamethasoneExonsGenetic LociGenetic VariationHigh-Throughput Nucleotide SequencingHumansInterferon-gammaIntronsOligonucleotidesPromoter Regions, Genetic5' Untranslated RegionsADRB2 protein, humanAzacitidineDexamethasoneInterferon-gammaNR3C1 protein, humanOligonucleotidesProtein IsoformsReceptors, Adrenergic, beta-2Receptors, GlucocorticoidRNA Caps

Identifiers

PMID26615195
PMCPMC4824077
OpenAlexW2314330335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.